Xiaofeng Lan
Papers
7 publications
Trials
0 clinical trials
Key Impact
Clinical ketamine/esketamine researcher whose work links repeated ketamine treatment with cognition, suicidality, and neuroimaging biomarkers in mood disorders.
Background & Research
Xiaofeng Lan appears as an author on multiple clinical studies of repeated intravenous ketamine and esketamine for major depressive disorder, suicidal ideation, and cognition. The publications associate Lan with the Affiliated Brain Hospital of Guangzhou Medical University in Guangzhou, China, and related psychiatry/neuroimaging work on treatment response and suicide outcomes.
Collaboration Network
5 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Depressive DisordersSuicidalityMajor Depressive Disorder (MDD)Bipolar DisorderAdolescentsAnxiety DisordersSchizophreniaOlder AdultsImmunology & InflammationHeadache Disorders (Cluster & Migraine)Safety & Risk ManagementChronic PainNeuroimaging & Brain MeasuresTreatment-Resistant Depression (TRD)Neurocognitive Disorders